Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2012 (2012), Article ID 540681, 7 pages
http://dx.doi.org/10.1155/2012/540681
Clinical Study

Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles

1Kamineni Fertility Centre, Kamineni Hospitals, King Koti, Hyderabad 500001, India
2Services of Gynecology and Obstetrics-Reproduction, The Bow Hospital, Chu de Nice, Route Saint Anton, 06200 Nice, France
3Centre for Reproductive Medicine-Barts and The London NHS Trust, London EC 1A 7BE, UK

Received 28 July 2011; Revised 12 October 2011; Accepted 17 October 2011

Academic Editor: Mario Maggi

Copyright © 2012 Srisailesh Vitthala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Golan and A. Weissman, “Symposium: update on prediction and management of OHSS. A modern classification of OHSS,” Reproductive BioMedicine Online, vol. 19, no. 1, pp. 28–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Binder, R. Dittrich, F. Einhaust et al., “Update on ovarian hyperstimulation syndrome: part 1—incidence and pathogenesis,” International Journal of Fertility and Women's Medicine, vol. 52, no. 1, pp. 11–26, 2007. View at Google Scholar
  3. M. R. Fluker, W. M. Hooper, and A. A. Yuzpe, “Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles,” Fertility and Sterility, vol. 71, no. 2, pp. 294–301, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Al-Shawaf, A. Zosmer, S. Hussain et al., “Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified “coasting” strategy based on ultrasound for identification of high-risk patients,” Human Reproduction, vol. 16, no. 1, pp. 24–30, 2001. View at Google Scholar · View at Scopus
  5. A. Delvigne, “Symposium: update on prediction and management of OHSS. Epidemiology of OHSS,” Reproductive BioMedicine Online, vol. 19, no. 1, pp. 8–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Roest, “Severe OHSS: an “epidemic” caused by doctors,” Human Reproduction, vol. 14, no. 9, p. 2183, 1999. View at Google Scholar · View at Scopus
  7. J. A. Stewart, P. J. Hamilton, and A. P. Murdoch, “Thromboembolic disease associated with ovarian stimulation and assisted conception techniques,” Human Reproduction, vol. 12, no. 10, pp. 2167–2173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Rizk and M. Aboulghar, “Modern management of ovarian hyperstimulation syndrome,” Human Reproduction, vol. 6, no. 8, pp. 1082–1087, 1991. View at Google Scholar · View at Scopus
  9. J. G. Whelan and N. F. Vlahos, “The ovarian hyperstimulation syndrome,” Fertility and Sterility, vol. 73, no. 5, pp. 883–896, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. G. Grudzinskas and P. E. Egbase, “Prevention of ovarian hyperstimulation syndrome: novel strategies,” Human Reproduction, vol. 13, no. 8, pp. 2051–2053, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Homburg and V. Insler, “Ovulation induction in perspective,” Human Reproduction Update, vol. 8, no. 5, pp. 449–462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Aboulghar, “Symposium: update on prediction and management of OHSS. Prevention of OHSS,” Reproductive BioMedicine Online, vol. 19, no. 1, pp. 33–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Abdalla and J. D. M. Nicopoullos, “The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation,” Fertility and Sterility, vol. 94, no. 5, pp. 1757–1763, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Sher, C. Zouves, M. Feinman, and G. Maassarani, “Prolonged coasting: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization,” Human Reproduction, vol. 10, no. 12, pp. 3107–3109, 1995. View at Google Scholar · View at Scopus
  15. C. A. Benadiva, M. Moomjy, O. Davis, H. C. Liu, I. Kligman, and Z. Rosenwaks, “Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome,” Fertility and Sterility, vol. 67, no. 4, pp. 724–727, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. D. V. Tortoriello, P. G. McGovern, J. M. Colón, J. H. Skurnick, K. Lipetz, and N. Santoro, “"Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients,” Fertility and Sterility, vol. 69, no. 3, pp. 454–460, 1998. View at Google Scholar · View at Scopus
  17. M. A. Aboulghar, R. T. Mansour, G. I. Serour, C. A. Rhodes, and Y. M. Amin, “Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation,” Journal of Assisted Reproduction and Genetics, vol. 17, no. 5, pp. 298–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. D'Angelo and N. N. Amso, “Embryo freezing for preventing ovarian hyperstimulation syndrome: a cochrane review,” Human Reproduction, vol. 17, no. 11, pp. 2787–2794, 2002. View at Google Scholar · View at Scopus
  19. R. Mansour, M. Aboulghar, G. Serour, Y. Amin, and A. M. Abou-Setta, “Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome,” Human Reproduction, vol. 20, no. 11, pp. 3167–3172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. D'Angelo and N. Amso, “Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD002811, 2002. View at Google Scholar · View at Scopus
  21. U. Ulug, M. Bahceci, H. F. Erden, E. Shalev, and I. Ben-Shlomo, “The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles,” Human Reproduction, vol. 17, no. 2, pp. 310–313, 2002. View at Google Scholar · View at Scopus
  22. L. G. Nardo, P. Cheema, T. A. Gelbaya et al., “The optimal length of “coasting protocol” in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization,” Human Fertility, vol. 9, no. 3, pp. 175–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Y. Hsu, M. Kubo, S. Y. Chun, F. G. Haluska, D. E. Housman, and A. J. W. Hsueh, “Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-α gene promoter,” Molecular Endocrinology, vol. 9, no. 10, pp. 1356–1366, 1995. View at Google Scholar · View at Scopus
  24. J. B. Brown, “Pituitary control of ovarian function—concepts derived from gonadotrophin therapy,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 18, no. 1, pp. 47–54, 1978. View at Google Scholar · View at Scopus
  25. I. E. Messinis and A. A. Templeton, “The importance of follicle-stimulating hormone increase for folliculogenesis,” Human Reproduction, vol. 5, no. 2, pp. 153–156, 1990. View at Google Scholar · View at Scopus
  26. M. M. Van Weissenbruch, H. C. Schoemaker, H. A. Drexhage, and J. Schoemaker, “Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease,” Human Reproduction, vol. 8, no. 6, pp. 813–821, 1993. View at Google Scholar · View at Scopus
  27. T. Al-Shawaf, A. Zosmer, A. Tozer, C. Gillott, A. M. Lower, and J. G. Grudzinskas, “Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS,” Human Reproduction, vol. 17, no. 5, pp. 1217–1221, 2002. View at Google Scholar · View at Scopus
  28. M. van Wely, I. Kwan, A. L. Burt et al., “Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles,” Cochrane Database of Systematic Reviews, vol. 2, Article ID CD005354, 2011. View at Google Scholar
  29. N. Yilmaz, D. Uygur, E. Ozgu, and S. Batioglu, “Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome?” Fertility and Sterility, vol. 94, no. 1, pp. 189–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. S. Gera, L. L. Tatpati, M. C. Allemand, M. A. Wentworth, and C. C. Coddington, “Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome,” Fertility and Sterility, vol. 94, no. 1, pp. 173–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. U. Waldenström, J. Kahn, L. Marsk, and S. Nilsson, “High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by “prolonged coasting” of very hyperstimulated patients: a multicentre study,” Human Reproduction, vol. 14, no. 2, pp. 294–297, 1999. View at Google Scholar · View at Scopus
  32. B. Ho Yuen, T. A. T. Nguyen, A. P. Cheung, and P. C. K. Leung, “Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting,” Fertility and Sterility, vol. 92, no. 2, pp. 499–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Erman Akar and K. Oktay, “Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld,” Archives of Gynecology and Obstetrics, vol. 280, no. 5, pp. 761–765, 2009. View at Publisher · View at Google Scholar · View at Scopus